Allakos マネジメント
マネジメント 基準チェック /34
Allakos' CEO is Robert Alexander, appointed in Apr 2017, has a tenure of 7.58 years. total yearly compensation is $6.30M, comprised of 12.8% salary and 87.2% bonuses, including company stock and options. directly owns 0.8% of the company’s shares, worth $903.61K. The average tenure of the management team and the board of directors is 3.6 years and 6.4 years respectively.
主要情報
Robert Alexander
最高経営責任者
US$6.3m
報酬総額
| CEO給与比率 | 12.8% |
| CEO在任期間 | 7.6yrs |
| CEOの所有権 | 0.8% |
| 経営陣の平均在職期間 | 3.6yrs |
| 取締役会の平均在任期間 | 6.4yrs |
経営陣の近況
Recent updates
We Think Allakos (NASDAQ:ALLK) Needs To Drive Business Growth Carefully
Aug 27
We're Keeping An Eye On Allakos' (NASDAQ:ALLK) Cash Burn Rate
May 05We're Keeping An Eye On Allakos' (NASDAQ:ALLK) Cash Burn Rate
Dec 01Companies Like Allakos (NASDAQ:ALLK) Are In A Position To Invest In Growth
Aug 03Allakos (NASDAQ:ALLK) Will Have To Spend Its Cash Wisely
Apr 20Is Allakos Inc. (NASDAQ:ALLK) Expensive For A Reason? A Look At Its Intrinsic Value
Jan 04Allakos: Potential For Comeback With Lirentelimab With 2 Indications
Oct 18Allakos prices ~$150M underwritten offering
Sep 19Allakos falls as lead asset offers mixed results in late-stage trial
Sep 09Allakos (NASDAQ:ALLK) Will Have To Spend Its Cash Wisely
Aug 06Will Allakos (NASDAQ:ALLK) Spend Its Cash Wisely?
Apr 22Allakos: Sad End To A Promising Asset
Dec 23We're Hopeful That Allakos (NASDAQ:ALLK) Will Use Its Cash Wisely
Dec 01We Think Allakos (NASDAQ:ALLK) Can Afford To Drive Business Growth
Aug 16Allakos: Upcoming Phase 3 Data Makes The Stock Interesting
Aug 06Allakos provides lirentelimab clinical trial enrollment updates, names new CMO
Jun 07We're Hopeful That Allakos (NASDAQ:ALLK) Will Use Its Cash Wisely
May 02Have Allakos Inc. (NASDAQ:ALLK) Insiders Been Selling Their Stock?
Mar 10Allakos Inc. (NASDAQ:ALLK) Insiders Have Been Selling
Jan 28
We're Interested To See How Allakos (NASDAQ:ALLK) Uses Its Cash Hoard To Grow
Dec 07Allakos EPS misses by $0.02
Nov 09CEO報酬分析
| 日付 | 総報酬 | 給与 | 会社業績 |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | -US$206m |
| Mar 31 2024 | n/a | n/a | -US$214m |
| Dec 31 2023 | US$6m | US$805k | -US$186m |
| Sep 30 2023 | n/a | n/a | -US$166m |
| Jun 30 2023 | n/a | n/a | -US$151m |
| Mar 31 2023 | n/a | n/a | -US$165m |
| Dec 31 2022 | US$7m | US$782k | -US$320m |
| Sep 30 2022 | n/a | n/a | -US$371m |
| Jun 30 2022 | n/a | n/a | -US$403m |
| Mar 31 2022 | n/a | n/a | -US$411m |
| Dec 31 2021 | US$11m | US$745k | -US$270m |
| Sep 30 2021 | n/a | n/a | -US$220m |
| Jun 30 2021 | n/a | n/a | -US$199m |
| Mar 31 2021 | n/a | n/a | -US$181m |
| Dec 31 2020 | US$14m | US$710k | -US$153m |
| Sep 30 2020 | n/a | n/a | -US$134m |
| Jun 30 2020 | n/a | n/a | -US$113m |
| Mar 31 2020 | n/a | n/a | -US$93m |
| Dec 31 2019 | US$13m | US$600k | -US$85m |
| Sep 30 2019 | n/a | n/a | -US$75m |
| Jun 30 2019 | n/a | n/a | -US$65m |
| Mar 31 2019 | n/a | n/a | -US$55m |
| Dec 31 2018 | US$8m | US$500k | -US$44m |
| Sep 30 2018 | n/a | n/a | -US$37m |
| Jun 30 2018 | n/a | n/a | -US$32m |
| Mar 31 2018 | n/a | n/a | -US$27m |
| Dec 31 2017 | US$1m | US$300k | -US$24m |
報酬と市場: Robert's total compensation ($USD6.30M) is above average for companies of similar size in the US market ($USD655.65K).
報酬と収益: Robert's compensation has been consistent with company performance over the past year.
CEO（最高経営責任者
Robert Alexander (54 yo)
7.6yrs
在職期間
US$6,299,426
報酬
Dr. Robert Alexander, Ph D., had been an Independent Director of Allena Pharmaceuticals, Inc. since June 2016 until 2022. He has been the Chief Executive Officer of Allakos Inc. since April 2017 and served...
リーダーシップ・チーム
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| CEO & Director | 7.6yrs | US$6.30m | 0.80% $ 903.6k | |
| President | 5.3yrs | US$4.27m | 0.35% $ 390.8k | |
| Chief Financial Officer | 3.6yrs | US$2.74m | データなし | |
| Chief Technical Officer | 1.3yrs | データなし | データなし | |
| Chief Medical Officer | less than a year | データなし | 0.32% $ 362.8k | |
| Director of Medical Affairs & Data Analytics | no data | データなし | データなし |
3.6yrs
平均在職期間
54yo
平均年齢
経験豊富な経営陣: ALLK's management team is considered experienced (3.6 years average tenure).
取締役
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| CEO & Director | 7.5yrs | US$6.30m | 0.80% $ 903.6k | |
| Independent Director | 7yrs | US$387.12k | 0% $ 0 | |
| Independent Director | 8.6yrs | US$387.12k | 0% $ 0 | |
| Independent Director | 1.3yrs | US$378.28k | 0% $ 0 | |
| Independent Director | 2.3yrs | US$372.12k | 0% $ 0 | |
| Independent Director | 6.4yrs | US$389.62k | 0% $ 0 | |
| Member of Scientific Advisory Board | no data | データなし | データなし | |
| Member of Scientific Advisory Board | no data | データなし | データなし | |
| Independent Director | 1.3yrs | US$732.48k | 0.044% $ 49.1k |
6.4yrs
平均在職期間
62yo
平均年齢
経験豊富なボード: ALLK's board of directors are considered experienced (6.4 years average tenure).